A2DMQY Cronos Group Inc

Spinach® Becomes the Number One Edible Brand in January¹

Spinach® Becomes the Number One Edible Brand in January¹

Spinach® gummies, known for incredible flavors and quality, are winning with adult consumers in the Canadian market

TORONTO, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, today announced that its award-winning gummies portfolio under the Spinach® brand has become the top-selling edible brand in Canada, capturing 15.8%1 market share of the total edibles category in January 2023.

Since launching in 2021, Spinach’s® portfolio of edibles under both SOURZ by Spinach™ and Spinach FEELZ™ have quickly risen to become the most popular edibles in Canada. These cannabis edibles deliver bold fruit flavor in a distinctive “S” shaped gummy with a sour and sweet flavor profile, featuring proprietary flavor-masking technology.

“Spinach® gummies were designed to enhance the experiences people share with their friends and they’ve changed the game in the edibles category,” said Jeff Jacobson, Chief Growth Officer, Cronos. “We are thrilled that our gummies have become favored by so many adult consumers, and we thank them for showing brand loyalty and enthusiasm for our products. We remain committed to quality, R&D, and breakthrough product development, and look forward to bringing more innovative and differentiated products to the market under the Spinach® brand.”

“Our strategy has always been to develop a best-in-class portfolio of disruptive branded products that we can launch in new markets as cannabis regulations open globally,” said Mike Gorenstein, Chairman, President and CEO, Cronos. “Our Spinach® gummies achieving #1 market share in Canada in January1 is validation of our innovation and marketing capabilities and encourages us as we prepare to further expand our portfolio of borderless products.” 

SOURZ by Spinach™ cannabis edibles are available in a variety of flavors and cannabinoid ratios: 

  • Peach Orange (1:1 THC:CBD)
    • 10mg THC & 10mg CBD per package
  • Blue Raspberry Watermelon (Indica)
    • 10mg THC per package
  • Strawberry Mango (Sativa)
    • 10mg THC per package
  • Cherry Lime (Hybrid)
    • 10mg THC per package
  • Tropical Triple Berry (Hybrid, 1:2 THC:CBD)
    • 10mg THC & 20mg CBD per package

Spinach’s® gummy portfolio also includes rare cannabinoids under the Spinach FEELZ™ brand in the following flavors and cannabinoid ratios:

  • CHILL BLISS Pineapple Starfruit (2:1 THC:CBG)
    • 10mg THC & 5mg CBG per package
  • DEEP DREAMZ Blueberry Pomegranate (2:1 THC:CBN)
    • 10mg THC & 5mg CBN per package
  • DAY TRIP Mango Lime (1:3 THC:CBC)
    • 10mg THC & 30mg CBC per package

The Spinach® gummies are imaginative and delicious edibles made to delight the senses – perfect for sharing with friends. For more information and availability, please visit: .

1 HiFyre Retail Analytics – National Edibles Retail Dollar Sales by Brand in Canada - January 1, 2023 to January 31, 2023.

About Cronos

Cronos is an innovative global cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology and product development. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio. Cronos’ diverse international brand portfolio includes Spinach®, PEACE NATURALS® and Lord Jones®. For more information about Cronos and its brands, please visit: thecronosgroup.com.

Forward-looking Statements

This press release may contain information that may constitute “forward-looking information” or “forward-looking statements” within the meaning of applicable Canadian and U.S. securities laws and court decisions (collectively, “Forward-looking Statements”). All information contained herein that is not clearly historical in nature may constitute Forward-looking Statements. In some cases, Forward-looking Statements can be identified by the use of forward-looking terminology such as “may”, “will”, “expect”, “plan”, “anticipate”, “intend”, “potential”, “estimate”, “believe” or the negative of these terms, or other similar expressions intended to identify Forward-looking Statements. Some of the Forward-looking Statements contained in this press release include statements about the launch of new products continuing to help increase Cronos’ market share. Forward-looking Statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable by management, are inherently subject to significant business, economic and competitive risks, financial results, results, performance or achievements expressed or implied by those Forward-looking Statements and the Forward-looking Statements are not guarantees of future performance. A discussion of some of the material risks applicable to the Company can be found in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 and Quarterly Report on Form 10-Q for the period ended September 30, 2022, both have which been filed on SEDAR and EDGAR and can be accessed at and /edgar, respectively. Any Forward-looking Statement included in this press release is made as of the date of this press release and, except as required by law, Cronos disclaims any obligation to update or revise any Forward-looking Statement. Readers are cautioned not to put undue reliance on any Forward-looking Statement.

For further information, please contact:

Media Relations Contact:

Emily Whalen

Communications

Tel: (416) 504-0004

Investor Relations Contact:

Shayne Laidlaw

Investor Relations

Tel: (416) 504-0004

 



EN
08/02/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Cronos Group Inc

 PRESS RELEASE

Cronos Group Reports 2025 Second Quarter Results

Cronos Group Reports 2025 Second Quarter Results Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong global demand Industry-leading balance sheet with $834 million in total cash and cash equivalents and short-term investments TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), today announced its 2025 second quarter business results. "Cronos delivered another quarter of str...

 PRESS RELEASE

Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call...

Cronos Group Inc. to Hold 2025 Second Quarter Earnings Conference Call on August 7, 2025 TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 second quarter earnings conference call on Thursday, August 7, 2025 at 8:30 a.m. ET. Cronos’ senior management team will discuss the Company’s financial results and will be available for questions from the investment community after prepared remarks. To attend the conference call or webcast, participants should register online at . To avoid delays, we encourage partic...

 PRESS RELEASE

Cronos Grows its International Footprint in Switzerland

Cronos Grows its International Footprint in Switzerland TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training. “We are excited to partner with Dascoli to bring high-quality medical cannabis to Swiss patients,” said Mike Gorenstein, Chairman, ...

 PRESS RELEASE

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Sharehol...

Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding. Each of the directors listed as a nominee in the Company’s definitive proxy statement dated April 25, 2025 was...

 PRESS RELEASE

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Co...

Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST. A live webcast will be available on the Investors section of the Company’s website at . About Cronos Group Inc.Cronos is an innovative global cannabinoid company...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch